Results 121 to 130 of about 11,371 (259)

Treatment of Idiopathic Restless Legs Syndrome (RLS) with the D2-agonist Cabergoline — An Open Clinical Trial [PDF]

, 2000
Karin Stiasny, Julia Röbbecke, Peter Schüler, Wolfgang H. Oertel   +3 more
openalex   +1 more source

Macroprolactinoma Shrinkage during Cabergoline Treatment Is Greater in Naive Patients Than in Patients Pretreated with Other Dopamine Agonists: A Prospective Study in 110 Patients1 [PDF]

, 2000
Annamaria Colao, Antonella Di Sarno, Maria Luisa Landi, Francesco Scavuzzo, Paolo Cappabianca, Rosario Pivonello, Raffaele Volpe, Francesco Di Salle, S. Cirillo, Lucio Annunziato, Gaetano Lombardi   +10 more
openalex   +1 more source

Evaluation of cabergoline as a reproductive inhibitor for coyotes (Canis latrans) [PDF]

, 2000
E. Seglund Amy, J. DeLiberto Thomas, A. Kimball Bruce   +2 more
openalex   +1 more source

A retrospective drug use evaluation of cabergoline for lactation inhibition at a tertiary care teaching hospital in Qatar

Therapeutics and Clinical Risk Management, 2016
Doua AlSaad,1 Samah ElSalem,1 Palli Valapila Abdulrouf,1 Binny Thomas,1,2 Tayseer Alsaad,3 Afif Ahmed,1 Moza AlHail4 1Department of Pharmacy, Women’s Hospital, Hamad Medical Corporation, Doha, Qatar; 2Department of Pharmacy and Life Sciences ...
AlSaad D, ElSalem S, Abdulrouf PV, Thomas B, Alsaad T, Ahmad A, AlHail M   +6 more
doaj  

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

Current Therapeutic Research, 2021
: Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like ...
Mohammed Fouad Shalaby, MD, Hekma A. Abd El Latif, PhD, Mohamed El Yamani, PhD, May Ahmed Galal, PhD, Sherifa Kamal, PhD, Ikhlas Sindi, PhD   +5 more
doaj  

Response to Treatment in a sample of Iraqi Patients with Prolactinoma

Medical Journal of Babylon
Background: Hyperprolactinemia is a common endocrine abnormality caused by physiological factors like pregnancy and lactation, drug-induced factors like antipsychotics, pituitary adenomas that secrete prolactin, or stalk compression or section that ...
Rana Kareem Mohammed, Abdullah Arnoos Abdulhasan, Shatha Mohammed Fezea   +2 more
doaj   +1 more source

ACTH silent adenoma shrinking under cabergoline [PDF]

, 2001
Patrick Pétrossians, N. Ronci, H. Valdes Socin, Anthony Kalife, Achille Stevenaert, Bertrand Bloch, Antoine Tabarin, Albert Beckers   +7 more
openalex   +1 more source

Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome [PDF]

, 2001
Enrico Papaleo, N. Doldi, Lucia De Santis, Guido Marelli, Elena Marsiglio, Simone Rofena, Augusto Ferrari   +6 more
openalex   +1 more source

Cabergolin

DMW - Deutsche Medizinische Wochenschrift, 2009
Mönig, H, Krack, Paul
openaire   +3 more sources

Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline [PDF]

, 2001
N. Erb
openalex   +1 more source